An open‐label pilot study of N‐acetylcysteine for skin‐picking in Prader–Willi syndrome
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Prader–Willi syndrome (PWS) is a complex neurodevelopmental disorder caused by an abnormality on the long arm of chromosome 15 (q11‐q13) that results in a host of behavioral characteristics including excessive interest in food, skin picking, difficulty with a change in routine, and obsessive and compulsive behaviors. Skin‐picking can result in serious and potentially life‐threatening infections. Recent evidence suggests that the excitatory neurotransmitter glutamate is dysregulated in obsessive‐compulsive behaviors, and modulation of the glutaminergic pathway may decrease compulsive behaviors, such as recurrent hair pulling or skin‐picking behaviors. N‐acetylcysteine (NAC), a derivative of the amino acid cysteine, is thought to act either via modulation of NMDA glutamate receptors or by increasing glutathione in pilot studies. Thirty‐five individuals with confirmed PWS (ages 5–39 years, 23 females/12 males) and skin‐picking behavior for more than 1 year were treated with N‐acetylcysteine (Pharma‐NAC®) at a dose of 450–1,200 mg/day. Skin‐picking symptoms and open lesions were assessed after 12 weeks of treatment by counting and measuring lesions before and after the medication. All 35 individuals had improvement in skin‐picking behaviors. Ten (29%) individuals (six males and four females) did not have complete resolution of skin‐picking behavior, but had significant reduction in the number of active lesions. Longer‐term, placebo‐controlled trials are needed to further assess the potential benefit of this treatment. © 2013 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grant, J. E., Odlaug, B. L., & Won Kim, S. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.60 · Cited by 424 · cited 2×
“…valproic Ac; GH, growth hormone; MEF, metformin; QPE, quetiapine; RSP, risperdone; SPR, spiro aLesions present for over 90 days prior to treatment. bPatient had in addition trichotillomania, which resolved with treatment. and nail biting [Grant et al., 2009; Rodrigues-Barata et al., 2012].”
BackgroundBerk, M., Dean, O., Cotton, S. M., Gama, C. S., Kapczinski, F., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Allwang, C., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.005 · Cited by 181 · cited 1×
“NAC has been shown to reduce the symptoms of both schizophrenia and bipolar disorder in early trials [Berk et al., 2011; Asevedo et al., 2012; Shungu, 2012].”
Simpson, H. B., Shungu, D. C., Bender, J., Mao, X., Xu, X., Slifstein, M., & Kegeles, L. S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.132 · Cited by 138 · cited 1×
“Glutamate (glutamic acid) is the most prominent neurotransmitter in the body, and it is the main excitatory neurotransmitter [Simpson et al., 2012].”
Background
Cited by
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update
Butler, M. G., Miller, J. L., & Forster, J. L. (2019) · Current Pediatric Reviews · doi:10.2174/1573396315666190716120925 · Cited by 355
Self-citationN-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial
Grant, J. E., Chamberlain, S. R., Redden, S. A., Leppink, E. W., Odlaug, B. L., & Kim, S. W. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0060 · Cited by 172
Oliver, G., Dean, O., Camfield, D., Blair-West, S., Ng, C., Berk, M., & Sarris, J. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.1.12 · Cited by 96
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Bradlow, R. C. J., Berk, M., Kalivas, P. W., Back, S. E., & Kanaan, R. A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00907-3 · Cited by 87
Selles, R. R., McGuire, J. F., Small, B. J., & Storch, E. A. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2016.04.001 · Cited by 80
Lee, D. K., & Lipner, S. R. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116370 · Cited by 47
Certainty of genuine treatment increases drug responses among intellectually disabled patients
Jensen, K. B., Kirsch, I., Pontén, M., Rosén, A., Yang, K., Gollub, R. L., des Portes, V., Kaptchuk, T. J., & Curie, A. (2017) · Neurology · doi:10.1212/wnl.0000000000003934 · Cited by 17
Metadata
- Authors
- Miller, J. L., & Angulo, M.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2013-12-05
- Volume
- 164
- Issue
- 2
- Pages
- 421-424
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W2018347382
- Cited by
- 71
- References
- 3
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.